Cargando...
Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
The global COVID-19 pandemic has caused massive disruptions in every society around the world. To help fight COVID-19, new molecular tools specifically targeting critical components of the causative agent of COVID-19, SARS-Coronavirus-2 (SARS-CoV-2), are desperately needed. The SARS-CoV-2 nucleocaps...
Gardado en:
| Publicado en: | bioRxiv |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Cold Spring Harbor Laboratory
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7480041/ https://ncbi.nlm.nih.gov/pubmed/32908982 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.09.03.280370 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|